Literature DB >> 22405962

Disturbed myocardial connexin 43 and N-cadherin expressions in hypoplastic left heart syndrome and borderline left ventricle.

Edris A F Mahtab1, Adriana C Gittenberger-de Groot, Rebecca Vicente-Steijn, Heleen Lie-Venema, Marry E B Rijlaarsdam, Mark G Hazekamp, Margot M Bartelings.   

Abstract

OBJECTIVES: Borderline left ventricle is the left ventricular morphology at the favorable end of the hypoplastic left heart syndrome. In contrast to the severe end, it is suitable for biventricular repair. Wondering whether it is possible to identify cases suitable for biventricular repair from a developmental viewpoint, we investigated the myocardial histology of borderline and severely hypoplastic left ventricles.
METHODS: Postmortem specimens of neonatal, unoperated human hearts with severe hypoplastic left heart syndrome and borderline left ventricle were compared with normal specimens and hearts from patients with transposition of the great arteries. After tissue sampling of the lateral walls of both ventricles, immunohistochemical and immunofluorescence stainings against cardiac troponin I, N-cadherin, and connexin 43, important for proper cardiac differentiation, were done.
RESULTS: All severely hypoplastic left hearts (7/7) and most borderline left ventricle hearts (4/6) showed reduced sarcomeric expressions of troponin I in left and right ventricles. N-cadherin and connexin 43 expressions were reduced in intercalated disks. The remaining borderline left ventricle hearts (2/6) were histologically closer to control hearts.
CONCLUSIONS: Four of 6 borderline left ventricle hearts showed myocardial histopathology similar to the severely hypoplastic left hearts. The remainder were similar to normal hearts. Our results and knowledge regarding the role of epicardial-derived cells in myocardial differentiation lead us to postulate that an abnormal epicardial-myocardial interaction could explain the observed histopathology. Defining the histopathologic severity with preoperative myocardial biopsy samples of hearts with borderline left ventricle might provide a diagnostic tool for preoperative decision making.
Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22405962     DOI: 10.1016/j.jtcvs.2012.02.011

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

1.  Impact of Hybrid Stage 1 Palliation for Hypoplastic Left Heart Syndrome: Histopathological Findings.

Authors:  Takashi Kido; Takaya Hoashi; Masataka Kitano; Masatoshi Shimada; Kenichi Kurosaki; Hatsue Ishibashi-Ueda; Hajime Ichikawa
Journal:  Pediatr Cardiol       Date:  2018-03-09       Impact factor: 1.655

Review 2.  Hypoplastic left heart syndrome (HLHS): molecular pathogenesis and emerging drug targets for cardiac repair and regeneration.

Authors:  Anthony T Bejjani; Neil Wary; Mingxia Gu
Journal:  Expert Opin Ther Targets       Date:  2021-09-15       Impact factor: 6.797

3.  Umbilical neutrophil gelatinase-associated lipocalin level as an early predictor of acute kidney injury in neonates with hypoplastic left heart syndrome.

Authors:  Piotr Surmiak; Małgorzata Baumert; Małgorzata Fiala; Zofia Walencka; Andrzej Więcek
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

4.  Rbfox2 function in RNA metabolism is impaired in hypoplastic left heart syndrome patient hearts.

Authors:  Sunil K Verma; Vaibhav Deshmukh; Curtis A Nutter; Elizabeth Jaworski; Wenhao Jin; Lalita Wadhwa; Joshua Abata; Marco Ricci; Joy Lincoln; James F Martin; Gene W Yeo; Muge N Kuyumcu-Martinez
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

5.  Re-evaluation of hypoplastic left heart syndrome from a developmental and morphological perspective.

Authors:  A Crucean; A Alqahtani; D J Barron; W J Brawn; R V Richardson; J O'Sullivan; R H Anderson; D J Henderson; B Chaudhry
Journal:  Orphanet J Rare Dis       Date:  2017-08-10       Impact factor: 4.123

6.  Functional and molecular effects of TNF-α on human iPSC-derived cardiomyocytes.

Authors:  Anita Saraf; Antonio Rampoldi; Myra Chao; Dong Li; Lawrence Armand; Hyun Hwang; Rui Liu; Rajnesh Jha; Haian Fu; Joshua T Maxwell; Chunhui Xu
Journal:  Stem Cell Res       Date:  2021-02-01       Impact factor: 2.020

Review 7.  The Left Ventricular Myocardium in Hypoplastic Left Heart Syndrome.

Authors:  Bill Chaudhry; Ahlam Alqahtani; Lorraine Eley; Louise Coats; Corina Moldovan; Srinivas R Annavarapu; Deborah J Henderson
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-19

8.  An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes.

Authors:  Yan Jiang; Saba Habibollah; Katarzyna Tilgner; Joseph Collin; Tomas Barta; Jumana Yousuf Al-Aama; Lenka Tesarov; Rafiqul Hussain; Andrew W Trafford; Graham Kirkwood; Evelyne Sernagor; Cyril G Eleftheriou; Stefan Przyborski; Miodrag Stojković; Majlinda Lako; Bernard Keavney; Lyle Armstrong
Journal:  Stem Cells Transl Med       Date:  2014-03-03       Impact factor: 6.940

9.  Role of connexins in human congenital heart disease: the chicken and egg problem.

Authors:  Aida Salameh; Katja Blanke; Ingo Daehnert
Journal:  Front Pharmacol       Date:  2013-06-03       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.